| Pharmaceutical active ingredients: |
| ChlorthalidoneOxprenolol Hydrochloride |
| Available forms, composition and doses of Slow-Trasitensine: |
| Tablets; Oral; Chlorthalidone 160 mg; Oxprenolol Hydrochloride 20 mg |
| Slow-Trasitensine medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07BA02 - Oxprenolol and thiazides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Logroton Retard | Chlorthalidone; Metoprolol Tartrate | Novartis; Zuellig Pharma |
| Lopresoretic | Chlorthalidone; Metoprolol Tartrate | Novartis |
| Lopressidone | Chlorthalidone; Metoprolol Tartrate | Novartis |
| Prelis Comp | Chlorthalidone; Metoprolol Tartrate | Novartis; Mibe Arzneimittel |
| Slow-Trasitensin | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |
| Trasitensin | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |
| Trasitensine | Chlorthalidone; Oxprenolol Hydrochloride | Novartis |
| Hygroton-K | Chlorthalidone; Potassium Chloride | Novartis |
| Darebon | Chlorthalidone; Reserpine | Novartis |
| Demi-Regroton | Chlorthalidone; Reserpine | Merck; Sanofi-Aventis |